Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide aptamers: new tools to study protein interactions.

F Hoppe-Seyler1, I Crnkovic-Mertens, C Denk

  • 1Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 242, D-69120, Heidelberg, Germany. hoppe-seyler@dkfz.de

The Journal of Steroid Biochemistry and Molecular Biology
|September 22, 2001
PubMed
Summary

Peptide aptamers are novel molecules designed to bind and inhibit disease-causing proteins within cells. This technology offers new avenues for drug design and protein therapy across various diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

Dalton transactions (Cambridge, England : 2003)·2024
Same author

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.

EJNMMI research·2016
Same author

Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.

British journal of cancer·2013
Same author

Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts.

Analytical biochemistry·2010
Same author

Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.

British journal of cancer·2007
Same author

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis.

Cellular and molecular life sciences : CMLS·2007

Area of Science:

  • Molecular Medicine
  • Biochemistry
  • Drug Discovery

Background:

  • Targeting pathological proteins is a long-standing goal in molecular medicine.
  • Developing specific inhibitors for intracellular protein function remains a challenge.

Purpose of the Study:

  • To introduce peptide aptamers as a novel class of molecules for targeting intracellular proteins.
  • To highlight their potential in inhibiting protein function and identifying therapeutic targets.

Main Methods:

  • Selection of peptide aptamers with specific binding affinity to target proteins under intracellular conditions.
  • Utilizing randomized peptide sequences for aptamer development.

Main Results:

  • Peptide aptamers demonstrate the ability to bind target proteins intracellularly.

Related Experiment Videos

  • They can inhibit the biochemical activities of target proteins.

    • Conclusions:

    • Peptide aptamers offer a new platform for drug design and protein therapy.
    • They have broad implications for research and treatment of diverse diseases.